Status:

COMPLETED

Heat and Cold Therapy for Chemotherapy-Induced Neuropathy

Lead Sponsor:

Bilecik Seyh Edebali Universitesi

Conditions:

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Eligibility:

FEMALE

18-75 years

Phase:

NA

Brief Summary

Cancer patients undergoing chemotherapy experience various side effects depending on the treatment protocol used. Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a dose-limiting and quality-of-li...

Detailed Description

Breast cancer patients undergoing chemotherapy experience various side effects depending on the treatment protocol used. The most common side effects include neutropenia, anemia, peripheral neuropathy...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Women with stage III-IV breast cancer receiving 4-7 cycles of taxane-based chemotherapy,
  • Patients with chemotherapy-induced neuropathy symptoms,
  • Residents of Ankara,
  • Over 18 years older,
  • No history of nerve damage or psychiatric illness,
  • No central nervous system metastasis or disease,
  • No irritation or ulceration in the skin area where the application will be made,
  • No history of deep vein thrombosis,
  • Not using anticoagulant medication,
  • Able to speak, understand, and read/write in Turkish,
  • Patients who consent to participate in the study will be included.
  • Exclusion Criteria
  • Patients with a history of nerve damage or psychiatric illness,
  • Ulcers or irritation in the area where the application will be made,
  • Patients with peripheral neuropathy developed due to reasons other than chemotherapy,
  • Patients who do not consent to participate in the study will be excluded.
  • Exclusion Criteria During the Study
  • Patients whose taxane treatment protocol is changed,
  • Patients who have less than four applications per week will be excluded from the study.

Exclusion

    Key Trial Info

    Start Date :

    March 3 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 16 2025

    Estimated Enrollment :

    108 Patients enrolled

    Trial Details

    Trial ID

    NCT06889129

    Start Date

    March 3 2025

    End Date

    July 16 2025

    Last Update

    July 18 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Gulhane Education and Research Hospital

    Ankara, Turkey (Türkiye), 06010